Although TAMs secreting arginase-1 are recognized to induce tumor immunosuppression in a wide variety of settings, it is not known whether TAM-T-cell interactions drive resistance to anti-PD1 plus chemotherapy in patients with CCA. Here, ARG1 is linked to neoplasm.